The CaMKII/GluN2B Protein Interaction Maintains Synaptic Strength

Area of Science:

• Neuroscience
• Molecular Biology
• Synaptic Plasticity

Background:

• Long-term potentiation (LTP) is vital for learning, memory, and cognition.
• LTP requires Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) binding to the NMDA-type glutamate receptor (NMDAR) subunit GluN2B for induction.
• The role of CaMKII/GluN2B binding in the maintenance of synaptic strength remains less understood.

Purpose of the Study:

• To investigate whether CaMKII/GluN2B binding mediates the maintenance of synaptic strength.
• To differentiate specific CaMKII/GluN2B-dependent effects from non-specific drug actions.

Main Methods:

• Utilized a pharmacogenetic approach with a mutant mouse lacking functional CaMKII binding to the NMDAR GluN2B subunit.
• Administered the CaMKII inhibitor tatCN21 at varying concentrations to assess synaptic strength.
• Analyzed presynaptic fiber volley amplitude and postsynaptic responses.

Main Results:

• The CaMKII inhibitor tatCN21 reduced synaptic strength at high concentrations (20 μm) but not low (5 μm).
• A nonspecific presynaptic component of tatCN21's effect was observed, independent of CaMKII/GluN2B interaction.
• The specific component of synaptic strength reduction was abolished in the GluN2B mutant mice, confirming CaMKII/GluN2B's role.

Conclusions:

• The CaMKII/GluN2B interaction is essential for both the induction and maintenance of synaptic strength.
• Pharmacogenetic strategies are critical for distinguishing specific molecular targets from off-target effects.
• This interaction is fundamental for enduring synaptic plasticity underlying cognitive functions.